UTIs are a pain in more ways than one.
They can also spread to the kidneys, which is when major problems begin to arise.
Abdominal pressure, nausea, and fatigue can also be symptoms.
Serious infections can even lead to fevers, according to Women’s Health.
Fortunately, most UTIs are treatable with a simple antibiotic.
However, a new medical discovery could help stop even the most stubborn cases in their tracks.
Dr. Keith Kaye, chief of infectious disease at Rutgers Robert Wood Johnson Medical School, gaveU.S.
Newsthe scoop on why some infections are so stubborn.
“It’s like we saw with COVID it’s evolution.
They will evolve to beat us and to beat our antibiotics.”
One of these evolutions involves ESBL, also known as extended-spectrum beta-lactamases.
These enzymes basically dissolve common antibiotics, rendering them useless.
Their new combination, cefepime/enmetazobactam, went up against the standard UTI treatment medication.
TheJournal of the American Medical Associationreported that the new combo of cefepime/enmetazobactam outperformed the standard treatment for UTIs.
In fact, it cured 79.1%, while the old medication, piperacillin/tazobactam, only helped 58.9%.
In the meantime,Healthlinedetails several steps you might take to prevent UTIs.
It’s also important to urinate before and after sex.
And, as always, drink plenty of water.
